Home › Acute Myeloid Leukemia › Illinois › Cicero
Acute Myeloid Leukemia clinical trials in Cicero, IL
11 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Loyola University Medical Center, Maywood · 5 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- and 2 more
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Loyola University Medical Center, Maywood · 5 mi away
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Children's Hospital-Oak Lawn, Oak Lawn · 9 mi away
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Loyola University Medical Center, Maywood · 5 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Loyola University Medical Center, Maywood · 5 mi away
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Loyola University Medical Center, Maywood · 5 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX86 studies
- New York City, NY51 studies
- Boston, MA45 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH34 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Tampa, FL29 studies
- Atlanta, GA29 studies
- Chicago, IL27 studies
- Portland, OR25 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Breast Cancer11 studies
- Colorectal Cancer9 studies
- Bladder Cancer8 studies
- Metastatic Cancer7 studies
- Cardiovascular Disease7 studies
- Melanoma7 studies
- Pancreatic Cancer6 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.